Sinclair Pharma Share Discussion Threads

[bigman] 02/12/2015 18:53

SoundBuy, totally agree better to travel forward now, but for different reason. The board should not be able to mess up counting money !! as they were not good at running the business they sold. How about cutting salaries Board members !!! after all not a great deal of business to manage for such huge salaries !! or better still gives us back a dividend.

[eggbaconandbubble] 02/12/2015 17:14

A 5p special divi would make the blonde happy!

[soundbuy] 02/12/2015 15:59

Well, the crock's gone for a fair wad, better than I expected (esp. after a yr.), leaving a clearer picture for the predators....with no further corporate action I'd rather be travelling on this leaner ship going fwd......

[bigman] 02/12/2015 08:47

The question is, does this disposal constitute the family silver sale ? and we are polishing our pewter up to look like gold ? maybe explains why share have not respond more positively. Definitely on the plus side a pile of cash will arrive for the board to play with !!! but will they half their salary now they have half a business to run ? and also no pressure from the banks over covenants, so that has to be good news.

[eggbaconandbubble] 27/11/2015 10:47

Thanks, rads. I thought it was 50%.

[rads] 27/11/2015 10:23

A company needs 75% of votes to change companr rules ie have complete control of the company, which they cant get without toscas agreement.

[eggbaconandbubble] 27/11/2015 10:19

mmmmmm! Anybody?

[scargs] 27/11/2015 10:08

eggbaconandbubble

The Toscafund will have to be comfortable with the takeover price.

Scargs

[eggbaconandbubble] 27/11/2015 09:48

Scargs,Yes! as we all know that they have done so for sometime now!

But why is that significant to a bidder that they require agreement for a takeover???

[scargs] 27/11/2015 09:36

eggbaconandbubble

The Toscafund, headed up by Martin Hughes, owns 29.5% of Sinclair IS Pharma.

Scargs

[eggbaconandbubble] 27/11/2015 09:15

Geoff Foster states that any bidder would have to reach agreement with Tosca. How is that or why is that?

[scargs] 27/11/2015 08:37

An interesting article on Sinclair IS Pharma in Geoff Foster's Market Report in today's Daily Mail.

The £127,500,000 cash sale of the company's medical dermatology business is worth 26.5p a share.

The Silhouette business, which is growing really fast, is attracting a lot of attention and a 60p bid target is possible.

The Indian press has reported that Lupin, the country's third largest drug maker was considering a 65p bid.

Keep your eye on this share.

[johnwise] 27/11/2015 08:25

Sinclair IS Pharma PLC Price Target Increased to GBX 60 by Analysts at Jefferies Group (SPH)

Sinclair IS Pharma PLC (LON:SPH) had its target price hoisted by equities researchers at Jefferies Group from GBX 45 ($0.68) to GBX 60 ($0.91) in a research report issued to clients and investors on Friday, Marketbeat reports. The firm currently has a “buy” rating on the specialty pharmaceutical company’s stock. Jefferies Group’s price target would suggest a potential upside of 57.89% from the stock’s previous close.


For over 50 years, Jefferies has measured success just one way: We only win when our clients win. What makes this approach so important today is not just our dedication to it, but that these values and character of work have never been more important to our clients.

[steeplejack] 27/11/2015 08:19

I thought the the price reaction to yesterday's news was strangely muted.Surprised the shares didn't nudge into the low 40s.Having held this stock since Maelor days,a 60p share price target is welcome news.Something concerning every dog having his day springs to mind.

[soundbuy] 27/11/2015 08:02

#SPH Jefferies BUY raises TP from 45p to 60p ....

[eggbaconandbubble] 26/11/2015 10:29

The remaining bit of the business is so attractive I imagine that they are frightened of a takeover and letting it go for a song.
Obvious thing to do would be to now take it private but can they do that with the big institutional holdings in place??

[soundbuy] 26/11/2015 10:13

The worry here was that the 'rump' left would be the disposal today - only a matter of time before aesthetics side disposed of......as they say:

'Creates a fast growth, high margin pure-play differentiated aesthetics company'

Interesting that the company '.....continues to receive attention with regards to the remaining aesthetics business from a number of international companies.....' after a yr on the mkt....' can see why this has taken so long...

Bidding war??? Hmmmm.......

[johnwise] 26/11/2015 09:25

Boystown 26 Nov'15 - 08:53 - 1112 of 1113 0 0
I'v seen it all many times before with companies like

Boystown, And so has Tosca and Soros and they will have had their teems of annalists go through this company's books and prospects with a fine toothed comb before investing such a large amount £££;££

Remember, DERAMPERS NEVER DERAMP A BAD SHARE. Watch the board for shares with no potential. They never have any derampers. Derampers only go after shares that are going upwards or have excellent potential to go up. Derampers get left behind, so they want to bring the price down to be able to get in at a great price

[steeplejack] 26/11/2015 09:12

With Tosca and Soros involved,I don't see the company being run for the management's benefit.

[boystown] 26/11/2015 08:53

Chris Spooner is the only one with a sig' stake at 1.81% - currently valued at £3.46m at 38.5pps.

He pulled in £765k last year and had a position of respect and authority & no doubt travelled the world and stayed in prestigious place etc etc., which is what this kind of motivation is really all about IMO - as opposed to delivering shareholder value. Today's deal keeps this going indefinitely.

What's more - as an Executive Director he can potentially receive 150% of salary under the Bonus Plan.

As I say, I really hope I'm wrong in this cynicism but I won't be investing as I've seen it all many times before with companies like this that can never actually move to a bottom line profit it seems.

[eggbaconandbubble] 26/11/2015 08:50

Be interesting to see if anyone of above tops up.

Are the directors allowed to at present under the takeover wotsit?

[johnwise] 26/11/2015 08:44

Large shareholdings in Sinclair IS Pharma

Director Shareholdings


Chris Spooner 8,989,164 Value £3,483,300.94

Jean-Charles Tschudin 3,000,117 Value £1,162,545.30

Grahame Cook 700,000 Value £271,249.99

Christophe Foucher 191,200 Value £74,090.00


Major Shareholdings

Toscafund Asset Management 144,799,596 Value £56,109,841.72


Lansdowne Partners Limited 59,987,523 Value£23,245,164.45


Abingworth LLP 33,433,227 Value £12,955,375.06


Soros Fund Management LLC 25,000,000 Value £9,687,499.70


Robert Stuart Swanson 19,986,280 Value £7,744,683.26

[eggbaconandbubble] 26/11/2015 08:35

Agreed steeplejack, - 'The Company is remaining in an offer period under the framework provided by a formal sales process under the Takeover Code as it continues to receive attention for the remaining aesthetics business from a number of international companies.'

That comment suggests that at worst the share price is supported from any downside.

[eggbaconandbubble] 26/11/2015 08:27

Boystown, 'those involved' have very large shareholdings!

[steeplejack] 26/11/2015 08:25

A net cash position of £82m post disposal represents approaching 50% of the market cap.If the aesthetics business is as attractive as the management maintain,the rump of the business is likely to attract a bid.